BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2699787)

  • 1. [Short term effects of ketoconazole in Cushing's syndrome].
    Cerdas S; Billaud L; Guilhaume B; Laudat MH; Bertagna X; Luton JP
    Ann Endocrinol (Paris); 1989; 50(6):489-96. PubMed ID: 2699787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.
    Sonino N; Boscaro M; Paoletta A; Mantero F; Ziliotto D
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):347-52. PubMed ID: 1752063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease].
    Tabarin A; Navarranne A; Corcuff B; Guerin J; Kern AM; Roger P
    Ann Endocrinol (Paris); 1990; 51(1):27-32. PubMed ID: 2171415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the treatment of Cushing's syndrome using ketoconazole].
    Conget JI; Halperin I; Vendrell J; Ferrer J; Martínez-Osaba MJ; Esmatjes E; Vilardell E
    Med Clin (Barc); 1989 Nov; 93(14):531-4. PubMed ID: 2695699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
    Engelhardt D; Jacob K; Doerr HG
    Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ketoconazole in pre-operative treatment in Cushing's syndrome: three cases report.
    Li KL; Tung SC; Wang PW
    Changgeng Yi Xue Za Zhi; 1996 Dec; 19(4):358-63. PubMed ID: 9041768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome.
    Moncet D; Morando DJ; Pitoia F; Katz SB; Rossi MA; Bruno OD
    Medicina (B Aires); 2007; 67(1):26-31. PubMed ID: 17408017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome.
    Tabarin A; Navarranne A; Guérin J; Corcuff JB; Parneix M; Roger P
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):63-9. PubMed ID: 2004474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged treatment of Cushing's disease by ketoconazole.
    Sonino N; Boscaro M; Merola G; Mantero F
    J Clin Endocrinol Metab; 1985 Oct; 61(4):718-22. PubMed ID: 4031015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol.
    Terzolo M; Panarelli M; Piovesan A; Torta M; Paccotti P; Angeli A
    J Endocrinol Invest; 1988 Nov; 11(10):717-21. PubMed ID: 2852693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
    Corcuff JB; Young J; Masquefa-Giraud P; Chanson P; Baudin E; Tabarin A
    Eur J Endocrinol; 2015 Apr; 172(4):473-81. PubMed ID: 25624013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
    Kong HL; Lee KO; Cheah JS
    Singapore Med J; 1992 Oct; 33(5):523-4. PubMed ID: 1455284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketoconazole in the treatment of Cushing's disease.
    Dash RJ; Khandekar S; Lata V; Bhansali A
    J Assoc Physicians India; 1990 Jul; 38(7):486-9. PubMed ID: 2292555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
    Komanicky P; Spark RF; Melby JC
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1042-51. PubMed ID: 233687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of Cushing's disease using ketoconazole. Possibility of therapeutic escape].
    Diop SN; Warnet A; Duet M; Firmin C; Mosse A; Lubetzki J
    Presse Med; 1989 Sep 2-9; 18(27):1325-8. PubMed ID: 2552430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.